Palantirs, Sovereign

Palantir's Sovereign AI Bet with Nvidia Collides with Europe's Sovereign Distrust

Published on 07/06/2026 at 09:02 | Redaktion boerse-global.de

Palantir surges 14% on Nvidia AI deal but faces European blacklisting, widening valuation swings as US revenue soars 85%.

Palantir's Two Lives: U.S. Nvidia Rally vs. European Government Blockades
Palantir's Sovereign AI Bet with Nvidia Collides with Europe's Sovereign Distrust Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The software group is living two lives. In the United States, a blockbuster alliance with Nvidia and record-breaking commercial growth are driving the stock back toward recovery territory. Across the Atlantic, however, European governments are systematically locking the door — and the tension is producing the widest valuation swings the company has seen in months.

The Nvidia Gamble on Trust

Palantir’s freshly expanded partnership with Nvidia targets the single biggest barrier to its international expansion: data sovereignty. By integrating its AIP and Foundry platforms with Nvidia’s open-source Nemotron models, the company is offering governments a controlled AI environment where sensitive data never leaves national boundaries. CEO Alex Karp has positioned the move as a direct rebuttal to the “data extraction” model of other US tech giants.

Markets rewarded the announcement immediately. In the first week of July, the share price surged about 14% in dollar terms. By Friday the stock closed at €112.28 in Europe, representing an 11% weekly gain. Yet even that bounce leaves the equity more than 20% below its level at the start of the year. In late June it touched a 52-week low of €93.30.

Europe’s Growing No-Fly Zone

The political headwinds are piling up fast. Spain’s state holding company SEPI has issued a formal recommendation to all its public and private portfolio companies against signing new contracts with Palantir, effectively blacklisting the firm for critical infrastructure and military technology. France’s domestic intelligence agency terminated its agreement in June in favour of a homegrown alternative. In the UK, the mayor of London blocked a multi-million-pound police deal.

Should investors sell immediately? Or is it worth buying Palantir?

The most visible European flashpoint remains the £330 million contract with the National Health Service. A growing chorus of politicians is calling for an exit by early 2027, though technical dependency makes a clean break unlikely. No domestic supplier currently has the capacity to handle the NHS’s data load.

Home-Field Advantage

Back in the US, the operational picture could hardly be stronger. Palantir reported its best-ever revenue growth earlier this year, with sales leaping 85% to $1.63 billion and net income reaching $871 million. The US commercial business posted a 133% year-over-year increase in revenue, while US government contracts grew 84%. The adjusted operating margin hit a stunning 60%.

New contract value climbed 61% to $2.41 billion, reinforcing the company’s shift toward the private sector. Palantir carries no debt and holds massive cash reserves — a cushion that matters given its rich valuation.

Palantir at a turning point? This analysis reveals what investors need to know now.

The Valuation Tightrope

At roughly $129 per share, the stock trades at 86 times expected earnings of $1.48 per share for the full year — a multiple that implies near-doubled profits from 2025. Analysts have set an average price target close to €160, banking on continued US momentum and a successful European pivot through the Nvidia deal.

But the market is pricing in a best-case scenario. If European government blockades turn structural and the sovereign AI offering fails to convert into binding contracts, the valuation quickly becomes untenable. The next major test comes with the quarterly report in August, when investors will scrutinise whether Nvidia’s firepower can bridge the trust gap — or whether Europe’s doors are closing for good.

Ad

Palantir Stock: New Analysis - 6 July

Fresh Palantir information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Palantir analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US69608A1088 | PALANTIRS | boerse | 69702517 |